As of the latest Form 4 filed Jul 2, 2026.
What Colgate-Palmolive Company insiders — officers, directors and 10% owners — have bought and sold in their own stock, straight from their SEC Form 4 filings. Values are shares × the reported transaction price where both are disclosed.
Buys plotted up, sells down; bar height is the disclosed dollar value (shares × reported price). Our Form 4 history is only complete from mid-2026, so early months are sparse — the series fills in as more filings land. Open-market purchases and sales only.
Newest filing first — the 51 most recent filings for CL.
| Filed | Trade date | Insider | Transaction | Shares | Price | Value | 10b5-1 | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-07-02 | 2026-07-01 | NORRINGTON LORRIE M Director | AAward | +293.00 | $89.45 | $26.2K | No | Form 4 ↗ |
| 2026-07-02 | 2026-07-01 | Newman Brian Director | AAward | +209.00 | $89.45 | $18.7K | No | Form 4 ↗ |
| 2026-07-02 | 2026-07-01 | BILBREY JOHN P Director | AAward | +265.00 | $89.45 | $23.7K | No | Form 4 ↗ |
| 2026-06-17 | 2026-06-16 | GRANT SHANE COO, Americas | FTax | −23.3K | $90.66 | $2.12M | No | Form 4 ↗ |
| 2026-05-18 | 2026-05-15 | Malcolm Gregory EVP and Controller | SSale | −2.30K | $88.44 | $203K | No | Form 4 ↗ |
| 2026-05-13 | 2026-05-11 | NORRINGTON LORRIE M Director | AAward | +2.08K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-13 | 2026-05-11 | Newman Brian Director | AAward | +2.08K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-13 | 2026-05-11 | Nelson Kimberly A Director | AAward | +2.08K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-13 | 2026-05-11 | HUNDMEJEAN MARTINA Director | AAward | +2.08K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-13 | 2026-05-11 | HARRIS C MARTIN Director | AAward | +1.56K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-13 | 2026-05-11 | Edwards Lisa Director | AAward | +2.08K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-13 | 2026-05-11 | CAHILL JOHN T Director | AAward | +2.08K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-13 | 2026-05-11 | BOERNER CHRISTOPHER S. Director | AAward | +1.38K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-13 | 2026-05-11 | BILBREY JOHN P Director | AAward | +2.08K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-11 | 2026-05-07 | Massey Sally Chief People Officer | SSale | −8.60K | $87.41 | $752K | No | Form 4 ↗ |
| 2026-04-03 | 2026-04-01 | NORRINGTON LORRIE M Director | AAward | +294.00 | $89.05 | $26.2K | No | Form 4 ↗ |
| 2026-04-03 | 2026-04-01 | Newman Brian Director | AAward | +210.00 | $89.05 | $18.7K | No | Form 4 ↗ |
| 2026-04-03 | 2026-04-01 | BILBREY JOHN P Director | AAward | +266.00 | $89.05 | $23.7K | No | Form 4 ↗ |
| 2026-02-25 | 2026-02-23 | Hazlin John Chief Growth Officer | FTax | −6.12K | $97.10 | $594K | No | Form 4 ↗ |
| 2026-02-25 | 2026-02-23 | Hazlin John, Chief Growth Officer | AAward | +12.8K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-25 | 2026-02-23 | Daniels Jennifer CLO and Secretary | FTax | −12.4K | $97.10 | $1.20M | No | Form 4 ↗ |
| 2026-02-25 | 2026-02-23 | Daniels Jennifer, CLO and Secretary | AAward | +25.7K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-25 | 2026-02-23 | Malcolm Gregory EVP and Controller | FTax | −2.26K | $97.10 | $219K | No | Form 4 ↗ |
| 2026-02-25 | 2026-02-23 | Malcolm Gregory, EVP and Controller | AAward | +6.27K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-25 | 2026-02-23 | Massey Sally Chief Human Resources Officer | FTax | −8.21K | $97.10 | $797K | No | Form 4 ↗ |
| 2026-02-25 | 2026-02-23 | Massey Sally, Chief Human Resources Officer | AAward | +16.8K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-25 | 2026-02-23 | SUTULA STANLEY J III Chief Financial Officer | FTax | −19.7K | $97.10 | $1.92M | No | Form 4 ↗ |
| 2026-02-25 | 2026-02-23 | SUTULA STANLEY J III, Chief Financial Officer | AAward | +38.7K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-25 | 2026-02-23 | Tsourapas Panagiotis COO, Eur., APac, Afr Eur, Skin | FTax | −13.1K | $97.10 | $1.27M | No | Form 4 ↗ |
| 2026-02-25 | 2026-02-23 | Tsourapas Panagiotis, COO, Eur., APac, Afr Eur, Skin | AAward | +25.7K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-25 | 2026-02-23 | Wallace Noel R. Chairman, President & CEO | FTax | −68.3K | $97.10 | $6.63M | No | Form 4 ↗ |
| 2026-02-25 | 2026-02-23 | Wallace Noel R., Chairman, President & CEO | AAward | +137K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-13 | 2026-02-12 | Tsourapas Panagiotis COO, Eur., APac, Afr Eur, Skin | SSale | −15.0K | $97.81 | $1.47M | No | Form 4 ↗ |
| 2026-02-13 | 2026-02-12 | Tsourapas Panagiotis, COO, Eur., APac, Afr Eur, Skin | MExercise | +15.0K | $76.41 | $1.15M | No | Form 4 ↗ |
| 2026-02-13 | 2026-02-11 | Tsourapas Panagiotis, COO, Eur., APac, Afr Eur, Skin | SSale | −35.0K | $94.61 | $3.31M | No | Form 4 ↗ |
| 2026-02-13 | 2026-02-11 | Tsourapas Panagiotis, COO, Eur., APac, Afr Eur, Skin | MExercise | +35.0K | $76.41 | $2.67M | No | Form 4 ↗ |
| 2026-02-12 | 2026-02-10 | Hazlin John Chief Growth Officer | SSale | −21.0K | $94.25 | $1.98M | No | Form 4 ↗ |
| 2026-02-12 | 2026-02-10 | Hazlin John, Chief Growth Officer | MExercise | +21.0K | $76.41 | $1.60M | No | Form 4 ↗ |
| 2026-02-10 | 2026-02-06 | Malcolm Gregory EVP and Controller | SSale | −12.7K | $94.91 | $1.21M | No | Form 4 ↗ |
| 2026-02-10 | 2026-02-06 | Malcolm Gregory, EVP and Controller | MExercise | +12.7K | $76.41 | $974K | No | Form 4 ↗ |
| 2026-02-09 | 2026-02-05 | Massey Sally Chief Human Resources Officer | SSale | −15.9K | $95.03 | $1.51M | No | Form 4 ↗ |
| 2026-02-09 | 2026-02-05 | Massey Sally, Chief Human Resources Officer | MExercise | +15.9K | $76.41 | $1.21M | No | Form 4 ↗ |
| 2026-02-06 | 2026-02-04 | SUTULA STANLEY J III Chief Financial Officer | SSale | −97.8K | $94.27 | $9.22M | No | Form 4 ↗ |
| 2026-02-06 | 2026-02-04 | SUTULA STANLEY J III, Chief Financial Officer | MExercise | +97.8K | $81.78 | $8.00M | No | Form 4 ↗ |
| 2026-02-06 | 2026-02-04 | Daniels Jennifer CLO and Secretary | SSale | −22.0K | $94.34 | $2.08M | No | Form 4 ↗ |
| 2026-02-06 | 2026-02-04 | Daniels Jennifer, CLO and Secretary | MExercise | +22.0K | $72.29 | $1.59M | No | Form 4 ↗ |
| 2026-02-06 | 2026-02-04 | Wallace Noel R. Chairman, President & CEO | SSale | −45.6K | $93.91 | $4.28M | No | Form 4 ↗ |
| 2024-05-03 | 2024-05-01 | Massey Sally Chief Human Resources Officer | SSale | −6.12K | $91.92 | $562K | No | Form 4 ↗ |
| 2024-05-03 | 2024-05-01 | Massey Sally, Chief Human Resources Officer | MExercise | +6.12K | $72.29 | $442K | No | Form 4 ↗ |
| 2024-05-03 | 2024-05-01 | BILBREY JOHN P Director | SSale | −6.33K | $91.59 | $580K | No | Form 4 ↗ |
| 2024-05-03 | 2024-05-01 | BILBREY JOHN P, Director | MExercise | +6.33K | $62.04 | $393K | No | Form 4 ↗ |
Insiders — a company’s officers, directors and holders of more than 10% of its stock — must report any trade in that stock to the SEC on a Form 4 within two business days. Each row here is one transaction from those filings.
The transaction code tells you what happened: Purchase (P) and Sale (S) are open-market trades — the ones markets watch most; Award (A) is a granted stock or unit, Option exercise (M) converts options into shares, and Gift (G) is a transfer for no consideration. Awards, exercises and gifts are largely compensation or administrative, not a directional bet.
One caveat on sales: many are made under a Rule 10b5-1 plan scheduled months in advance, so a sale is not automatically a bearish signal. Insider activity is a noisy input — read it alongside the filings, not on its own.
See also CL’s full analysis or the market-wide insider trading feed. The tabs above jump to CL’s other SEC data.
Source: SEC Form 4 filings for CL, parsed from EDGAR. Transaction prices are as reported in the filing — SEC public-domain data, not market quotes. Values are shares × reported price where both are disclosed; grants and gifts often carry no price. A delayed record of what insiders reported, not a live position or a recommendation.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.